Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Enteropathy-Associated T-Cell Lymphoma × Methotrexate × 1 year × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 51 Burkitt Lymphoma 26 Leukemia, Myeloid, Acute 14 Leukemia, Biphenotypic, Acute 12 Myelodysplastic Syndromes 11 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10 Leukemia 9 Lymphoma, Mantle-Cell 6 Lymphoma 6 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 5 Osteosarcoma 5 Medulloblastoma 5 Lymphoma, Non-Hodgkin 5 Lymphoma, Large B-Cell, Diffuse 5 Leukemia, Myeloid, Accelerated Phase 5 Blast Crisis 5 Recurrence 4 Hematologic Neoplasms 4 Graft vs Host Disease 4 Urinary Bladder Neoplasms 3 Primary Myelofibrosis 3 Neoplasm Metastasis 3 Myeloproliferative Disorders 3 Leukemia, Myelomonocytic, Juvenile 3 Blastic Plasmacytoid Dendritic Cell Neoplasm 3 Thrombocythemia, Essential 2 Rhabdoid Tumor 2 Polycythemia Vera 2 Neoplasm, Residual 2 Myelodysplastic-Myeloproliferative Diseases 2

Interventions

Cyclophosphamide 3 etoposide phosphate 2 Prednisone 2 Etoposide 2 Doxorubicin 2 Brentuximab Vedotin 2 tazemetostat 1 prednylidene 1 pembrolizumab 1 fludarabine 1 deltacortene 1 Vincristine 1 Prednisolone 1 Melphalan 1 Cytarabine 1 Cholecalciferol 1 Carmustine 1 10-propargyl-10-deazaaminopterin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡